Enfusion Long Term Debt

Enfusion (ENFN) currently reports a long-term debt of $14M as of December 2024. That compares with $11M in the prior-year period — up 27.3% year over year. Use the charts on this page to explore Enfusion's long-term debt history and peer comparisons.

Enfusion's long-term debt increased from $11M to $14M — a 27.3% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Enfusion reported $14M in long-term debt as of December 2024. That compares with $11M in the prior-year period — up 27.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Enfusion, and consider following ENFN for alerts when major investors trade the stock.

Enfusion is classified in the Technology sector. On long-term debt, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing ENFN with unrelated industries.